KESTREL INVESTMENT MANAGEMENT CORP - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 45 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
KESTREL INVESTMENT MANAGEMENT CORP ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q2 2014$619,000
-61.0%
137,500
-61.0%
0.08%
-60.9%
Q1 2014$1,586,000
-46.2%
352,350
-39.0%
0.20%
-45.7%
Q4 2013$2,950,000
+8.3%
577,339
-4.0%
0.36%
+29.6%
Q3 2013$2,724,000
-15.2%
601,339
-4.4%
0.28%
-21.3%
Q2 2013$3,214,000628,9390.36%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2014
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,218,401$6,957,0004.07%
BARD ASSOCIATES INC 395,575$2,260,0000.21%
Ariel Investments 1,290,317$7,368,0000.08%
Ballew Advisors, Inc 5,557$31,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 205,400$1,173,0000.01%
DELTA ASSET MANAGEMENT LLC/TN 12,000$68,0000.01%
Oakworth Capital, Inc. 3,052$17,0000.00%
Spark Investment Management LLC 10,800$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 878,348$5,015,0000.00%
Renaissance Technologies 381,471$2,178,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders